Security key
090572207
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)
CUSIP: 090572207
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Class B Common Stock
- Total 13F shares
- 19,370,183
- Total 13F value
- $6,481,921,085
- Share change
- -807,208
- Put/Call ratio
- 71%
- SEC-reported price per share
- $334.58
- Number of holders
- 433
- Value change
- -$218,781,622
- Number of buys
- 189
- Number of sells
- 231
- Shares outstanding
- 5,071,025
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
433
Top holders
10
BIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
BIO-RAD LABORATORIES, INC. SEC filings
BIO-RAD LABORATORIES, INC. company facts
BIO-RAD LABORATORIES, INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 090572207
Recent filing periods:
Ownership snapshot
Top reported holders of BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
13D/G
Lead comparable stake: 8.4%
13D/G row: VANGUARD GROUP INC
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 8.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
8.4%
BlackRock Finance, Inc.
31%
Veritas Asset Management LLP
22%
STATE STREET CORP
17%
VAN ECK ASSOCIATES CORP
13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group - 23-1945930
|
8.4%
from 13D/G
|
$648,501,607
2,374,507 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
31%
|
$423,475,820
1,550,569 shares
|
— | 30 Jun 2024 |
| Veritas Asset Management LLP |
13F
Company
|
22%
|
$308,289,572
1,128,811 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
17%
|
$234,844,831
859,891 shares
|
— | 30 Jun 2024 |
| VAN ECK ASSOCIATES CORP |
13F
Company
|
13%
|
$180,040,000
659,222 shares
|
— | 30 Jun 2024 |
| Select Equity Group, L.P. |
13F
Company
|
13%
|
$177,390,953
649,522 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
433
Shares
19,370,183
Rows available
433
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
428
Q3 2024 holders
433
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend